Administrative Slip or Permanent Stain? The Fragile Line in Inam Butt's Doping Case

A contract usually has one page. A dirty contract has an entire appendix. But in Inam Butt's file, there is no appendix at all. Only a positive urine sample, a late TUE application, and a silver medal from the Asian Beach Games in April now facing the risk of permanent forfeiture. As the ITA — the International Testing Agency based in Lausanne — promised to issue its decision within a week, all of Pakistan holds its breath to see whether a world champion, a national team head coach, a Pakistan Wrestling Federation (PWF) secretary-general, and a Pakistan Olympic Association (POA) athletes' commission chairman will have his honor restored or be permanently marked by the global anti-doping system. This is not the typical doping case that sports investigators chase: no performance-enhancing powders, no clandestine growth hormone, no organized conspiracy, no slush fund appearing in a third-country bank account. This is the story of an athlete with an eye condition, prescribed medication by a doctor, using it to continue competing — and forgetting to seek ITA permission before use. Administrative error, or violation of anti-doping rules? This line is so thin that even the most honest athletes can inadvertently cross it. In over a decade of following amateur wrestling in Asia, I have witnessed many cases where people used the 'I forgot' excuse to conceal intent. But the Inam Butt case does not belong to that category. Look at his position: a man who simultaneously competes, coaches, manages a federation, and represents athletes. This is the kind of role concentration I have seen often in countries with modest sports budgets and thin administrative staff. They let a few exceptional individuals carry multiple positions at once. It works as a stopgap solution, but it also creates potential conflicts of interest that few dare to mention. Inam is not a stranger to anyone following beach wrestling. His title of 'former world champion' is not a bought medal or a trivial honor. Beach wrestling, a relatively new discipline under United World Wrestling (UWW), is contested on sand, without shirts, without protective gear, with faster and more exciting rules than traditional freestyle wrestling. Its competitive pyramid is still younger than Olympic freestyle wrestling, with fewer participating nations, but to claim a UWW-sanctioned world title, an athlete must navigate a brutal qualification system against opponents from Russia, Iran, India, and Mongolia. Then in April this year, at the Asian Beach Games, Inam won the silver medal in the 92kg category. That is a respectable achievement, a medal any athlete would be proud of. But that pride did not last long. His post-competition urine sample tested positive for a metabolite of medication used to treat an eye condition. Publicly available information shows Inam never denied taking the medication. He admitted using it to treat his eyes but acknowledged failing to obtain a TUE — Treatment Use Exemption — before use. That is the crux of the entire case. What is a TUE? In the global anti-doping system run by WADA, if an athlete must use a prohibited medication to treat a genuine medical condition, they may apply for a TUE — an exemption allowing the use of the medication for therapeutic purposes, provided it does not enhance performance beyond restoring normal health. The process requires medical records, a specialist's prescription, and review by an independent panel of medical experts before approval — or, in exceptional emergency cases, after use. But the rules do not allow indefinite delay. If an athlete uses medication without a TUE, regardless of how legitimate the medical reason is, they have violated the rules. Whether the active substance is confirmed to provide no performance benefit or not, using a prohibited substance without a permit is, in itself, a violation under the principle of strict liability. This is one of the most controversial principles in modern sport: you do not need to intend to cheat to be sanctioned. The mere presence of a prohibited substance in your body constitutes a violation. Inam Butt is not among the rare few fully exonerated. Reports describe the ITA as having 'accepted the medical explanation' and confirmed 'the medication was not intended to enhance performance,' yet simultaneously found that he was 'negligent' in not securing a TUE in time. This is a technical distinction that outsiders find hard to grasp: they say he did not cheat, but he is still at fault. That is the gap between 'unintentional' and 'intentional' — and in the anti-doping system, both carry consequences, albeit at different levels. What made me pause when reading the file was a small but significant contradiction. On one hand, sources say Inam 'failed to obtain the necessary TUE in time.' On the other hand, the same sources say the ITA 'granted permission for the medication for a one-year period.' How can one simultaneously lack a TUE and possess a one-year TUE? The answer lies in the retroactive TUE mechanism. In circumstances meeting emergency criteria or with clear medical evidence, WADA allows retroactive TUE applications. The ITA, after reviewing Inam's medical records, granted retroactive permission for a specific period — possibly one year, covering the time of the Asian Beach Games competition. I have written about too many doping cases in which athletes tried to circumvent the rules by faking illness, buying prescriptions from lenient doctors, or finding a 'specialist' willing to sign fabricated documents. But Inam's case is not like that. Precisely because his position — national team head coach, PWF secretary-general, POA athletes' commission chairman — makes him too prominent to 'forget' innocently. Someone in his position, if intentionally cheating, would know that even the smallest mistake could be exposed. So why would he let a childish administrative error like missing a TUE deadline happen? One possibility I consider worth exploring is negligence born from workload and role pressure. An athlete who is simultaneously a coach, a federation official, and a representative of other athletes does not have the administrative support staff that athletes in wealthier countries usually have. In Pakistan, a wrestler does not have a team of managers, lawyers, and medical experts like European or North American athletes do. He handles everything himself. And in a dense competition season, from domestic tournaments to international events, from coaching duties to administrative obligations, missing a paperwork deadline is entirely possible. But saying that does not mean I am defending him. In the WADA system, ignorance is not a defense. And I, after years of investigating doping cases, believe that principle is correct — unless we want to open the door to all forms of cheating disguised as 'I forgot.' What makes this case interesting is not the likelihood that Inam will be stripped of his medal — that is almost certain. It is the design of the expected sanction: a roughly two-month suspension, backdated from April. If the ITA officially announces that expected sanction, Inam will be absent for about two months — which means almost no impact on his competition schedule for the rest of the year, especially if major tournaments occur after June. More importantly, this absence will not cost him eligibility for future Asian Games. Why so short a ban, when international practice for prohibited substances is usually two to four years? The answer lies in a clause rarely discussed: degree of fault. Under the WADA World Anti-Doping Code, sanctions can be reduced in cases of 'no significant fault or negligence.' This is a legal concept, not a moral one. It does not say the athlete is faultless. It says the fault does not rise to a serious level, and therefore the sanction can fall below the usual minimum. When the ITA accepts the medical explanation, confirms the medication was not performance-enhancing, and simultaneously imposes a short backdated suspension, that signals the ITA views this as an administrative oversight case, not intentional doping. The sanction is symbolic — meant to remind athletes to respect procedure, not to punish someone who was dishonest. I have followed multiple Asian Games cycles over the years, and I have recognized one thing: anti-doping decisions are never purely legal. They always sit within a broader political and sporting context. A developing country like Pakistan, with an exceptional athlete carrying multiple roles, will not want to lose him to an unnecessary medical case. And the ITA, as an independent international body, wants to demonstrate firmness against cheating while avoiding unnecessary injustice. The Inam Butt case sits at the intersection of those two pressures. But here is a story rarely told: the severity of strict liability. Even if the ITA acknowledges the medication was therapeutic, even if there is no performance-enhancing benefit, even if the sanction is a short two months — the silver medal will still be stripped. That is not a choice. It is an automatic consequence of a prohibited substance appearing in his sample. In English, it is called 'forfeiture of results.' For those who watched or followed the final at the Asian Beach Games in April, they will remember how Inam competed. I was not there, but according to a local colleague's account, Inam entered the final with the courage of a veteran: no longer possessing the speed of his twenties, but compensating with match reading, distance management, and exploiting every small opening from his opponent. He lost in the final but still secured silver. That medal, under anti-doping law, has no value against a positive test. Even if the substance was eye medication. Look back at the day Inam decided to resign. Before the ITA announced its decision, he voluntarily stepped down from his positions as PWF secretary-general and POA athletes' commission chairman. His stated reason: for the interest of the sport and fairness. This step, I believe, was not accidental. In any sports governance system, a person under doping investigation who remains in management and athlete-representation roles is an untenable contradiction. He may have received legal advice, or realized himself that continuing to hold executive positions would damage the credibility of both PWF and POA. But this action also carries another layer of meaning: it is a way to preserve his post-athletic career. In an amateur sports ecosystem, where there are no lucrative contracts or transfer bonuses, federation positions are the most valuable asset of a former athlete. When Inam voluntarily leaves before judgment, he demonstrates cooperation and avoids being forced out — a form of 'self-sanctioning in advance' that may soften public and institutional reactions. Consider the broader context. In Pakistan, wrestling is not a commercialized sport like cricket. There is no PPV revenue, no major sponsors, no broadcast rights deals. Wrestlers rely on national stipends, tournament bonuses, and administrative positions within the sports system. A long suspension would mean lost income and lost status. A short, backdated ban is therefore not just a lenient legal outcome — it is the door for Inam to quickly return to the grind, preserve his positions, and turn this case into an expensive but non-career-ending lesson. The story deepens when placed against the Tianhai case I pursued for three years. In that case, murky finances were what exposed the entire collapse. But in this case, the exposure is not money flow but time: the seven months from a positive test to the ITA decision. Seven months for a man with three roles in the sports system to be suspended between 'innocent' and 'violation.' I want to pivot to a different angle. Most people reading this news will think: lucky for Inam, a reasonable leniency, an administrative error not worth sacrificing a career over. But viewed from the opposite side — a federation trying to educate athletes, an anti-doping body trying to send a deterrent message — the Inam Butt case could be a dangerous precedent. Imagine a young athlete in another developing country. He reads this story: a world champion used a prohibited substance, forgot to obtain a TUE, but got only a two-month ban and can still compete at the Asian Games. The message he receives could be: using prohibited substances, if backed by a medical reason, is not too serious. Apply for a TUE later, or even skip it, as long as you have a plausible health reason. That is the trap of leniency. I am not saying Inam deserves a harsher penalty. I am saying that every lenient sanction, however fair for the individual, is a signal to the system. And the anti-doping system stands on a fragile line between fairness for individual cases and deterrence for the many. An overly light sanction for a famous athlete in a developing country may inadvertently send a message the ITA does not intend. There is another factor I believe should be addressed candidly: the resource disparity within the global anti-doping system. An athlete in Norway or France who falls ill will have lawyers, specialist doctors, and TUE experts handling every step. An athlete in Pakistan must fend for himself. When mistakes happen, wealthier athletes can file retroactive TUEs with complete documentation, while poorer athletes struggle to be heard. The ITA may not deliberately create this injustice, but the reality of smaller sports nations is unfolding exactly that way. So what does the Inam Butt story leave behind? First, it shows that the difference between cheating and medical error is a real gray zone — one that cannot be denied by a rigid regulation. Second, it shows that an exceptional athlete in a poorer country must carry too many roles at once: competing, coaching, managing. That role concentration is both an admirable quality and a systemic risk. I once wrote in an investigation on doping in Russia: 'The laboratory does not know the athlete's name. That is why I trust it.' In this case, I would add: the arena may be clean, but the changing room — where decisions are made about who gets to use which medication, when, and with which permit — is where the real scrutiny is needed. And the TUE, a tool designed to protect athletes with legitimate medical needs, has become a fragile sheet of paper distinguishing honor from infamy. Inam Butt may return to the Asian Games. He may keep his positions as head coach, secretary-general, and athletes' commission chairman. But the April silver medal will never belong to him again. And the price of an administrative mistake — however large or small — will remain in his file like an indelible ink stain, a reminder that in elite sport, forgetting a piece of paper can sometimes cost as much as throwing a match. The final question I want to ask is not whether Inam Butt deserves punishment or not — it is: why was an athlete diagnosed with an eye condition, prescribed legitimate medication, not urged by those around him to obtain a TUE in time? Who is responsible for this gap — the athlete, the doctor, the federation, or a system so complex that even insiders get confused?